speb/financial-data huggingface dataset:
CPRT income_statement (quarterly, 2026-04-30) — +Operating Expense: 108317000.00
CPRT income_statement (quarterly, 2026-04-30) — +Total Revenue: 1237066000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 598290000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 794472000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 1207201000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -14636000.00
CPRT income_statement (quarterly, 2026-04-30) — Basic Average Shares: 936293000.00
CPRT income_statement (quarterly, 2026-04-30) — Basic EPS: 0.43
CPRT cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 5101821000.00
CPRT cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -80893000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 93116000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Capital Stock: 93000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 3354142000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 4199712000.00
CPRT cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -1409846000.00
CPRT cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -925151000.00
CPRT cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 584198000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 33193000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Income Tax Payable: 19659000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Inventory: -7859000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Other Current Assets: 11904000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: 2459000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Payable: 52852000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 52852000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: -16381000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Receivables: 67621000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Tax Payable: 19659000.00
CPRT cash_flow (quarterly, 2026-04-30) — Change In Working Capital: 110596000.00
CPRT cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: 67522000.00
CPRT cash_flow (quarterly, 2026-04-30) — Changes In Cash: -1750799000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Common Stock: 93000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 8774264000.00
CPRT cash_flow (quarterly, 2026-04-30) — Common Stock Payments: -1414353000.00
CPRT income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 664467000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Current Assets: 5216673000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 15825000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 15825000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Current Deferred Assets: 117979000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 33494000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 33494000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 685259000.00
CPRT cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: 2272000.00
CPRT cash_flow (quarterly, 2026-04-30) — Deferred Tax: 2272000.00
CPRT cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 59086000.00
CPRT cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 59086000.00
CPRT income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 942770000.00
CPRT income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.43
CPRT income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 402401000.00
CPRT income_statement (quarterly, 2026-04-30) — EBIT: 464282000.00
CPRT income_statement (quarterly, 2026-04-30) — EBITDA: 523368000.00
CPRT cash_flow (quarterly, 2026-04-30) — Earnings Losses From Equity Investments: -22000.00
CPRT cash_flow (quarterly, 2026-04-30) — Effect Of Exchange Rate Changes: 3120000.00
CPRT cash_flow (quarterly, 2026-04-30) — End Cash Position: 3354142000.00
CPRT cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -1409846000.00
CPRT cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 503305000.00
CPRT cash_flow (quarterly, 2026-04-30) — Gain Loss On Sale Of PPE: 1879000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -87207000.00
CPRT income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 108317000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Goodwill: 522703000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 576646000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Gross Accounts Receivable: 809108000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Gross PPE: 3803988000.00
CPRT income_statement (quarterly, 2026-04-30) — Gross Profit: 572599000.00
CPRT cash_flow (quarterly, 2026-04-30) — Income Tax Paid Supplemental Data: 88067000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Income Tax Payable: 37650000.00
CPRT income_statement (quarterly, 2026-04-30) — Interest Income: 38813000.00
CPRT income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 38813000.00
CPRT cash_flow (quarterly, 2026-04-30) — Interest Paid Supplemental Data: 223000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Inventory: 49632000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Invested Capital: 8774264000.00
CPRT cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -925151000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Long Term Capital Lease Obligation: 77291000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 77291000.00
CPRT cash_flow (quarterly, 2026-04-30) — Long Term Debt Payments: -5000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Minority Interest: 17181000.00
CPRT income_statement (quarterly, 2026-04-30) — Minority Interests: 1008000.00
CPRT cash_flow (quarterly, 2026-04-30) — Net Business Purchase And Sale: -53000.00
CPRT cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: -1414353000.00
CPRT income_statement (quarterly, 2026-04-30) — Net Income: 402401000.00
CPRT income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 402401000.00
CPRT income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 401393000.00
CPRT income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 402401000.00
CPRT income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 402401000.00
CPRT cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 401393000.00
CPRT income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 401393000.00
CPRT income_statement (quarterly, 2026-04-30) — Net Interest Income: 38813000.00
CPRT cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: -845570000.00
CPRT cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: -5000.00
CPRT cash_flow (quarterly, 2026-04-30) — Net Long Term Debt Issuance: -5000.00
CPRT income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 38813000.00
CPRT cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: -572000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Net PPE: 3803988000.00
CPRT cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -79528000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 8197618000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 89733000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Liabilities: 89733000.00
CPRT income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 523368000.00
CPRT income_statement (quarterly, 2026-04-30) — Normalized Income: 402401000.00
CPRT cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 584198000.00
CPRT cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: 1857000.00
CPRT income_statement (quarterly, 2026-04-30) — Operating Income: 464282000.00
CPRT income_statement (quarterly, 2026-04-30) — Operating Revenue: 1237066000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 925811482.00
CPRT balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 54157000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: -87207000.00
CPRT income_statement (quarterly, 2026-04-30) — Other Gand A: 108317000.00
CPRT income_statement (quarterly, 2026-04-30) — Other Income Expense: -1001000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Other Intangible Assets: 53943000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 51729000.00
CPRT income_statement (quarterly, 2026-04-30) — Other Non Operating Income Expenses: -1001000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Other Properties: 3803988000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Other Short Term Investments: 845570000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Payables: 635940000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 635940000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Preferred Stock: 0.00
CPRT income_statement (quarterly, 2026-04-30) — Pretax Income: 502094000.00
CPRT cash_flow (quarterly, 2026-04-30) — Proceeds From Stock Option Exercised: 5084000.00
CPRT cash_flow (quarterly, 2026-04-30) — Provisionand Write Offof Assets: -469000.00
CPRT cash_flow (quarterly, 2026-04-30) — Purchase Of Business: -53000.00
CPRT cash_flow (quarterly, 2026-04-30) — Purchase Of Investment: -845570000.00
CPRT cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -80893000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Receivables: 795193000.00
CPRT income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 664467000.00
CPRT income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 59086000.00
CPRT cash_flow (quarterly, 2026-04-30) — Repayment Of Debt: -5000.00
CPRT cash_flow (quarterly, 2026-04-30) — Repurchase Of Capital Stock: -1414353000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Retained Earnings: 7654177000.00
CPRT cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 0.00
CPRT cash_flow (quarterly, 2026-04-30) — Sale Of PPE: 1365000.00
CPRT income_statement (quarterly, 2026-04-30) — Selling General And Administration: 108317000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Share Issued: 925811482.00
CPRT cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 9463000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 8774264000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 8197618000.00
CPRT income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
CPRT income_statement (quarterly, 2026-04-30) — Tax Provision: 100701000.00
CPRT income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.20
CPRT balance_sheet (quarterly, 2026-04-30) — Taxes Receivable: 721000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Total Assets: 9649036000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 8774264000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Total Debt: 93116000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 8791445000.00
CPRT income_statement (quarterly, 2026-04-30) — Total Expenses: 772784000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 857591000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 4432363000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 172332000.00
CPRT income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: 464282000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Total Tax Payable: 37650000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Tradeand Other Payables Non Current: 5308000.00
CPRT balance_sheet (quarterly, 2026-04-30) — Working Capital: 4531414000.00
CPRX balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 0.00
CPRX balance_sheet (annual, 2021-12-31) — Dueto Related Parties Non Current: 0.00
CPRX cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 292000.00
CPRX balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 9000.00
CPRX cash_flow (annual, 2021-12-31) — Operating Gains Losses: 292000.00
CPRX balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: -148000.00
CPRX income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 282000.00
CPRX balance_sheet (annual, 2021-12-31) — Other Receivables: 105000.00
CPRX balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 19821000.00
CPRX balance_sheet (annual, 2021-12-31) — Prepaid Assets: 3919000.00
CPRX cash_flow (annual, 2021-12-31) — Sale Of Investment: 0.00
CPRX balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 0.00
CPRX income_statement (annual, 2022-12-31) — +Operating Expense: 77972000.00
CPRX income_statement (annual, 2022-12-31) — +Total Revenue: 214203000.00
CPRX balance_sheet (annual, 2022-12-31) — Accounts Payable: 3975000.00
CPRX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 10439000.00
CPRX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -406000.00
CPRX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 250430000.00
CPRX income_statement (annual, 2022-12-31) — Amortization: 1098000.00
CPRX cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1098000.00
CPRX cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 1098000.00
CPRX income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 1098000.00
CPRX income_statement (annual, 2022-12-31) — Basic Average Shares: 103374606.00
CPRX income_statement (annual, 2022-12-31) — Basic EPS: 0.80
CPRX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 171445000.00
CPRX cash_flow (annual, 2022-12-31) — Capital Expenditure: -29000.00
CPRX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3894000.00
CPRX balance_sheet (annual, 2022-12-31) — Capital Stock: 105000.00
CPRX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 298395000.00
CPRX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 298395000.00
CPRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1694000.00
CPRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 9209000.00
CPRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 116047000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Account Payable: 1207000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 16391000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Inventory: 1065000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -307000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Payable: 1207000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 17598000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -807000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Receivables: -3820000.00
CPRX cash_flow (annual, 2022-12-31) — Change In Working Capital: 13729000.00
CPRX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -3820000.00
CPRX cash_flow (annual, 2022-12-31) — Changes In Cash: 126950000.00
CPRX balance_sheet (annual, 2022-12-31) — Common Stock: 105000.00
CPRX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 300421000.00
CPRX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CPRX cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
CPRX income_statement (annual, 2022-12-31) — Cost Of Revenue: 34393000.00
CPRX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 26077000.00
CPRX balance_sheet (annual, 2022-12-31) — Current Assets: 320806000.00
CPRX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 337000.00
CPRX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 337000.00
CPRX balance_sheet (annual, 2022-12-31) — Current Liabilities: 57588000.00
CPRX cash_flow (annual, 2022-12-31) — Deferred Income Tax: 4937000.00
CPRX cash_flow (annual, 2022-12-31) — Deferred Tax: 4937000.00
CPRX cash_flow (annual, 2022-12-31) — Depreciation: 141000.00
CPRX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1239000.00
CPRX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 1098000.00
CPRX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1239000.00
CPRX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1098000.00
CPRX income_statement (annual, 2022-12-31) — Diluted Average Shares: 111375631.00
CPRX income_statement (annual, 2022-12-31) — Diluted EPS: 0.75
CPRX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 83079000.00
CPRX balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 13127000.00
CPRX balance_sheet (annual, 2022-12-31) — Dueto Related Parties Non Current: 14064000.00
CPRX income_statement (annual, 2022-12-31) — EBIT: 101838000.00
CPRX income_statement (annual, 2022-12-31) — EBITDA: 103077000.00
CPRX cash_flow (annual, 2022-12-31) — End Cash Position: 298395000.00
CPRX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1694000.00
CPRX balance_sheet (annual, 2022-12-31) — Finished Goods: 1262000.00
CPRX cash_flow (annual, 2022-12-31) — Free Cash Flow: 116018000.00
CPRX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 762000.00
CPRX cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 247000.00
CPRX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 24000.00
CPRX income_statement (annual, 2022-12-31) — General And Administrative Expense: 28714000.00
CPRX balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 32471000.00
CPRX balance_sheet (annual, 2022-12-31) — Gross PPE: 4023000.00
CPRX income_statement (annual, 2022-12-31) — Gross Profit: 179810000.00
CPRX cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 7667000.00
CPRX balance_sheet (annual, 2022-12-31) — Income Tax Payable: 8702000.00
CPRX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
CPRX balance_sheet (annual, 2022-12-31) — Interest Payable: 0.00
CPRX balance_sheet (annual, 2022-12-31) — Inventory: 6805000.00
CPRX balance_sheet (annual, 2022-12-31) — Invested Capital: 300421000.00
CPRX cash_flow (annual, 2022-12-31) — Investing Cash Flow: 9209000.00
CPRX balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
CPRX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CPRX balance_sheet (annual, 2022-12-31) — Leases: 980000.00
CPRX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3557000.00
CPRX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3557000.00
CPRX balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
CPRX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 273000.00
CPRX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CPRX income_statement (annual, 2022-12-31) — Net Income: 83079000.00
CPRX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 83079000.00
CPRX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 83079000.00
CPRX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 83079000.00
CPRX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 83079000.00
CPRX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 83079000.00
CPRX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 83079000.00
CPRX cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
CPRX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 19238000.00
CPRX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -7875000.00
CPRX cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -10000000.00
CPRX balance_sheet (annual, 2022-12-31) — Net PPE: 3617000.00
CPRX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -29000.00
CPRX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 267950000.00
CPRX balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 18736000.00
CPRX balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 18736000.00
CPRX balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 9000.00
CPRX income_statement (annual, 2022-12-31) — Normalized EBITDA: 103077000.00
CPRX income_statement (annual, 2022-12-31) — Normalized Income: 83079000.00
CPRX cash_flow (annual, 2022-12-31) — Operating Cash Flow: 116047000.00
CPRX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 762000.00
CPRX income_statement (annual, 2022-12-31) — Operating Income: 101838000.00
CPRX income_statement (annual, 2022-12-31) — Operating Revenue: 214203000.00
CPRX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 105263031.00
CPRX balance_sheet (annual, 2022-12-31) — Other Current Assets: 354000.00
CPRX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 238000.00
CPRX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 24000.00
CPRX income_statement (annual, 2022-12-31) — Other Gand A: 22536000.00
CPRX income_statement (annual, 2022-12-31) — Other Income Expense: 2881000.00
CPRX balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 32471000.00
CPRX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 4394000.00
CPRX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 14064000.00
CPRX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 2881000.00
CPRX balance_sheet (annual, 2022-12-31) — Other Payable: 13127000.00
CPRX balance_sheet (annual, 2022-12-31) — Other Properties: 2770000.00
CPRX balance_sheet (annual, 2022-12-31) — Other Receivables: 354000.00
CPRX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 0.00
CPRX balance_sheet (annual, 2022-12-31) — Payables: 25804000.00
CPRX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 51881000.00
CPRX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5132000.00
CPRX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CPRX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 4813000.00
CPRX income_statement (annual, 2022-12-31) — Pretax Income: 104719000.00
CPRX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 9569000.00
CPRX balance_sheet (annual, 2022-12-31) — Properties: 0.00
CPRX cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
CPRX cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
CPRX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -29000.00
CPRX balance_sheet (annual, 2022-12-31) — Raw Materials: 0.00
CPRX balance_sheet (annual, 2022-12-31) — Receivables: 10793000.00
CPRX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 34252000.00
CPRX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1239000.00
CPRX cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
CPRX income_statement (annual, 2022-12-31) — Research And Development: 19789000.00
CPRX balance_sheet (annual, 2022-12-31) — Retained Earnings: 49862000.00
CPRX income_statement (annual, 2022-12-31) — Salaries And Wages: 6178000.00
CPRX cash_flow (annual, 2022-12-31) — Sale Of Investment: 19238000.00
CPRX income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 29469000.00
CPRX income_statement (annual, 2022-12-31) — Selling General And Administration: 57085000.00
CPRX balance_sheet (annual, 2022-12-31) — Share Issued: 105263031.00
CPRX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 7907000.00
CPRX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 300421000.00
CPRX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 267950000.00
CPRX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CPRX income_statement (annual, 2022-12-31) — Tax Provision: 21640000.00
CPRX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CPRX balance_sheet (annual, 2022-12-31) — Total Assets: 375630000.00
CPRX balance_sheet (annual, 2022-12-31) — Total Capitalization: 300421000.00
CPRX balance_sheet (annual, 2022-12-31) — Total Debt: 3894000.00
CPRX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 300421000.00
CPRX income_statement (annual, 2022-12-31) — Total Expenses: 112365000.00
CPRX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 75209000.00
CPRX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 54824000.00
CPRX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 17621000.00
CPRX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 101838000.00
CPRX balance_sheet (annual, 2022-12-31) — Total Tax Payable: 8702000.00
CPRX balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 14064000.00
CPRX cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CPRX balance_sheet (annual, 2022-12-31) — Work In Process: 5543000.00
CPRX balance_sheet (annual, 2022-12-31) — Working Capital: 263218000.00
CPRX income_statement (annual, 2023-12-31) — +Operating Expense: 259425000.00
CPRX income_statement (annual, 2023-12-31) — +Total Revenue: 398204000.00
CPRX balance_sheet (annual, 2023-12-31) — Accounts Payable: 14795000.00
CPRX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 53514000.00
CPRX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -723000.00
CPRX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 266488000.00
CPRX income_statement (annual, 2023-12-31) — Amortization: 32565000.00
CPRX cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 32565000.00
CPRX cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 32565000.00
CPRX income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 32565000.00
CPRX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CPRX income_statement (annual, 2023-12-31) — Basic Average Shares: 106279736.00
CPRX income_statement (annual, 2023-12-31) — Basic EPS: 0.67
CPRX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 298395000.00
CPRX cash_flow (annual, 2023-12-31) — Capital Expenditure: -81744000.00
CPRX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 3557000.00
CPRX balance_sheet (annual, 2023-12-31) — Capital Stock: 107000.00
CPRX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 137636000.00
CPRX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 137636000.00
CPRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -10857000.00
CPRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -293502000.00
CPRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 143600000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Account Payable: 10820000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 5800000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Inventory: -4739000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -338000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Payable: 10820000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 16620000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -5792000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Receivables: -43075000.00
CPRX cash_flow (annual, 2023-12-31) — Change In Working Capital: -37324000.00
CPRX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -43075000.00
CPRX cash_flow (annual, 2023-12-31) — Changes In Cash: -160759000.00
CPRX balance_sheet (annual, 2023-12-31) — Common Stock: 107000.00
CPRX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 387881000.00
CPRX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CPRX cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CPRX income_statement (annual, 2023-12-31) — Cost Of Revenue: 51967000.00
CPRX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 38282000.00
CPRX balance_sheet (annual, 2023-12-31) — Current Assets: 219329000.00
CPRX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 369000.00
CPRX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 369000.00
CPRX balance_sheet (annual, 2023-12-31) — Current Liabilities: 76063000.00
CPRX cash_flow (annual, 2023-12-31) — Deferred Income Tax: -17818000.00
CPRX cash_flow (annual, 2023-12-31) — Deferred Tax: -17818000.00
CPRX cash_flow (annual, 2023-12-31) — Depreciation: 316000.00
CPRX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 32881000.00
CPRX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 32565000.00
CPRX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 32881000.00
CPRX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 32565000.00
CPRX income_statement (annual, 2023-12-31) — Diluted Average Shares: 113753154.00
CPRX income_statement (annual, 2023-12-31) — Diluted EPS: 0.63
CPRX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 71410000.00
CPRX income_statement (annual, 2023-12-31) — EBIT: 86812000.00
CPRX income_statement (annual, 2023-12-31) — EBITDA: 119693000.00
CPRX cash_flow (annual, 2023-12-31) — End Cash Position: 137636000.00
CPRX cash_flow (annual, 2023-12-31) — Financing Cash Flow: -10857000.00
CPRX balance_sheet (annual, 2023-12-31) — Finished Goods: 9161000.00
CPRX cash_flow (annual, 2023-12-31) — Free Cash Flow: 61856000.00
CPRX cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 262000.00
CPRX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 3024000.00
CPRX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 14000.00
CPRX income_statement (annual, 2023-12-31) — General And Administrative Expense: 47021000.00
CPRX balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 194049000.00
CPRX balance_sheet (annual, 2023-12-31) — Gross PPE: 4426000.00
CPRX income_statement (annual, 2023-12-31) — Gross Profit: 346237000.00
CPRX cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 50458000.00
CPRX balance_sheet (annual, 2023-12-31) — Income Tax Payable: 729000.00
CPRX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 705000.00
CPRX balance_sheet (annual, 2023-12-31) — Interest Payable: 1031000.00
CPRX balance_sheet (annual, 2023-12-31) — Inventory: 15644000.00
CPRX balance_sheet (annual, 2023-12-31) — Invested Capital: 387881000.00
CPRX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -293502000.00
CPRX balance_sheet (annual, 2023-12-31) — Investments And Advances: 16489000.00
CPRX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CPRX balance_sheet (annual, 2023-12-31) — Leases: 991000.00
CPRX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 3188000.00
CPRX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3188000.00
CPRX balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 16489000.00
CPRX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 927000.00
CPRX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CPRX income_statement (annual, 2023-12-31) — Net Income: 71410000.00
CPRX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 71410000.00
CPRX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 71410000.00
CPRX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 71410000.00
CPRX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 71410000.00
CPRX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 71410000.00
CPRX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 71410000.00
CPRX cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -81513000.00
CPRX income_statement (annual, 2023-12-31) — Net Interest Income: 4675000.00
CPRX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -13465000.00
CPRX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 4675000.00
CPRX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -13649000.00
CPRX cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -198293000.00
CPRX balance_sheet (annual, 2023-12-31) — Net PPE: 3703000.00
CPRX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -231000.00
CPRX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 193832000.00
CPRX balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 36544000.00
CPRX balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 36544000.00
CPRX income_statement (annual, 2023-12-31) — Normalized EBITDA: 119693000.00
CPRX income_statement (annual, 2023-12-31) — Normalized Income: 71410000.00
CPRX cash_flow (annual, 2023-12-31) — Operating Cash Flow: 143600000.00
CPRX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 262000.00
CPRX income_statement (annual, 2023-12-31) — Operating Income: 86812000.00
CPRX income_statement (annual, 2023-12-31) — Operating Revenue: 398204000.00
CPRX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 107121549.00
CPRX balance_sheet (annual, 2023-12-31) — Other Current Assets: 351000.00
CPRX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 465000.00
CPRX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 14000.00
CPRX income_statement (annual, 2023-12-31) — Other Gand A: 34252000.00
CPRX income_statement (annual, 2023-12-31) — Other Income Expense: 7699000.00
CPRX balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 194049000.00
CPRX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 83225000.00
CPRX balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 485000.00
CPRX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 7699000.00
CPRX balance_sheet (annual, 2023-12-31) — Other Payable: 12540000.00
CPRX balance_sheet (annual, 2023-12-31) — Other Properties: 2508000.00
CPRX balance_sheet (annual, 2023-12-31) — Other Receivables: 138000.00
CPRX balance_sheet (annual, 2023-12-31) — Payables: 28064000.00
CPRX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 66346000.00
CPRX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8883000.00
CPRX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CPRX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 12046000.00
CPRX income_statement (annual, 2023-12-31) — Pretax Income: 94511000.00
CPRX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 2792000.00
CPRX balance_sheet (annual, 2023-12-31) — Properties: 0.00
CPRX cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -81513000.00
CPRX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -13465000.00
CPRX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -231000.00
CPRX balance_sheet (annual, 2023-12-31) — Raw Materials: 1910000.00
CPRX balance_sheet (annual, 2023-12-31) — Receivables: 53652000.00
CPRX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 51651000.00
CPRX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 32881000.00
CPRX cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
CPRX income_statement (annual, 2023-12-31) — Research And Development: 93150000.00
CPRX balance_sheet (annual, 2023-12-31) — Retained Earnings: 121272000.00
CPRX income_statement (annual, 2023-12-31) — Salaries And Wages: 12769000.00
CPRX cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
CPRX income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 86689000.00
CPRX income_statement (annual, 2023-12-31) — Selling General And Administration: 133710000.00
CPRX balance_sheet (annual, 2023-12-31) — Share Issued: 107121549.00
CPRX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 14250000.00
CPRX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 387881000.00
CPRX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 193832000.00
CPRX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CPRX income_statement (annual, 2023-12-31) — Tax Provision: 23101000.00
CPRX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.24
CPRX balance_sheet (annual, 2023-12-31) — Total Assets: 470114000.00
CPRX balance_sheet (annual, 2023-12-31) — Total Capitalization: 387881000.00
CPRX balance_sheet (annual, 2023-12-31) — Total Debt: 3557000.00
CPRX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 387881000.00
CPRX income_statement (annual, 2023-12-31) — Total Expenses: 311392000.00
CPRX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 82233000.00
CPRX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 250785000.00
CPRX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 6170000.00
CPRX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 86812000.00
CPRX income_statement (annual, 2023-12-31) — Total Other Finance Cost: -4675000.00
CPRX balance_sheet (annual, 2023-12-31) — Total Tax Payable: 729000.00
CPRX income_statement (annual, 2023-12-31) — Total Unusual Items: 3024000.00
CPRX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 3024000.00
CPRX balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 2497000.00
CPRX balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CPRX cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -3024000.00
CPRX balance_sheet (annual, 2023-12-31) — Work In Process: 4573000.00
CPRX balance_sheet (annual, 2023-12-31) — Working Capital: 143266000.00
CPRX cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -259000.00
CPRX balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 14842000.00
CPRX income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -4537000.00
CPRX balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 610000.00
CPRX income_statement (annual, 2024-12-31) — +Operating Expense: 227765000.00
CPRX income_statement (annual, 2024-12-31) — +Total Revenue: 491734000.00
CPRX balance_sheet (annual, 2024-12-31) — Accounts Payable: 16593000.00
CPRX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 65476000.00
CPRX balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 536000.00
CPRX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1120000.00
CPRX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 442286000.00
CPRX income_statement (annual, 2024-12-31) — Amortization: 37377000.00
CPRX cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 37377000.00
CPRX cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 37377000.00
CPRX income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 37377000.00
CPRX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
CPRX income_statement (annual, 2024-12-31) — Basic Average Shares: 118457673.00
CPRX income_statement (annual, 2024-12-31) — Basic EPS: 1.38
CPRX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 137636000.00
CPRX cash_flow (annual, 2024-12-31) — Capital Expenditure: -556000.00
CPRX cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -88000.00
CPRX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3188000.00
CPRX balance_sheet (annual, 2024-12-31) — Capital Stock: 121000.00
CPRX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 517553000.00
CPRX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 517553000.00
CPRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 140665000.00
CPRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -556000.00
CPRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 239808000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Account Payable: 1798000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 53848000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Inventory: -3897000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -369000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Payable: 1798000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 55646000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -8504000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Receivables: -11962000.00
CPRX cash_flow (annual, 2024-12-31) — Change In Working Capital: 30914000.00
CPRX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -11962000.00
CPRX cash_flow (annual, 2024-12-31) — Changes In Cash: 379917000.00
CPRX balance_sheet (annual, 2024-12-31) — Common Stock: 121000.00
CPRX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 727632000.00
CPRX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 141000000.00
CPRX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CPRX cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
CPRX income_statement (annual, 2024-12-31) — Cost Of Revenue: 68845000.00
CPRX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 88044000.00
CPRX balance_sheet (annual, 2024-12-31) — Current Assets: 623609000.00
CPRX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 402000.00
CPRX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 402000.00
CPRX balance_sheet (annual, 2024-12-31) — Current Liabilities: 120678000.00
CPRX cash_flow (annual, 2024-12-31) — Deferred Income Tax: -9388000.00
CPRX cash_flow (annual, 2024-12-31) — Deferred Tax: -9388000.00
CPRX cash_flow (annual, 2024-12-31) — Depreciation: 397000.00
CPRX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 37774000.00
CPRX income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 37377000.00
CPRX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 37774000.00
CPRX income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 37377000.00
CPRX income_statement (annual, 2024-12-31) — Diluted Average Shares: 124943603.00
CPRX income_statement (annual, 2024-12-31) — Diluted EPS: 1.31
CPRX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 163889000.00
CPRX income_statement (annual, 2024-12-31) — EBIT: 195124000.00
CPRX income_statement (annual, 2024-12-31) — EBITDA: 232898000.00
CPRX cash_flow (annual, 2024-12-31) — End Cash Position: 517553000.00
CPRX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 140665000.00
CPRX balance_sheet (annual, 2024-12-31) — Finished Goods: 9578000.00
CPRX cash_flow (annual, 2024-12-31) — Free Cash Flow: 239252000.00
CPRX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 5075000.00
CPRX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 64000.00
CPRX income_statement (annual, 2024-12-31) — General And Administrative Expense: 66396000.00
CPRX balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 156672000.00
CPRX balance_sheet (annual, 2024-12-31) — Gross PPE: 4704000.00
CPRX income_statement (annual, 2024-12-31) — Gross Profit: 422889000.00
CPRX cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 68451000.00
CPRX balance_sheet (annual, 2024-12-31) — Income Tax Payable: 894000.00
CPRX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1395000.00
CPRX balance_sheet (annual, 2024-12-31) — Interest Payable: 389000.00
CPRX balance_sheet (annual, 2024-12-31) — Inventory: 19541000.00
CPRX balance_sheet (annual, 2024-12-31) — Invested Capital: 727632000.00
CPRX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -556000.00
CPRX balance_sheet (annual, 2024-12-31) — Investments And Advances: 21564000.00
CPRX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 141000000.00
CPRX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CPRX balance_sheet (annual, 2024-12-31) — Leases: 991000.00
CPRX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2786000.00
CPRX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2786000.00
CPRX balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 21564000.00
CPRX balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 21564000.00
CPRX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1483000.00
CPRX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 141000000.00
CPRX income_statement (annual, 2024-12-31) — Net Income: 163889000.00
CPRX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 163889000.00
CPRX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 163889000.00
CPRX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 163889000.00
CPRX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 163889000.00
CPRX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 163889000.00
CPRX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 163889000.00
CPRX cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CPRX cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CPRX income_statement (annual, 2024-12-31) — Net Interest Income: 16064000.00
CPRX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CPRX cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CPRX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 16064000.00
CPRX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -13850000.00
CPRX balance_sheet (annual, 2024-12-31) — Net PPE: 3584000.00
CPRX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -556000.00
CPRX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 570960000.00
CPRX balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 45982000.00
CPRX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 45982000.00
CPRX income_statement (annual, 2024-12-31) — Normalized EBITDA: 227823000.00
CPRX income_statement (annual, 2024-12-31) — Normalized Income: 160042150.00
CPRX cash_flow (annual, 2024-12-31) — Operating Cash Flow: 239808000.00
CPRX income_statement (annual, 2024-12-31) — Operating Income: 195124000.00
CPRX income_statement (annual, 2024-12-31) — Operating Revenue: 491734000.00
CPRX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 120879099.00
CPRX balance_sheet (annual, 2024-12-31) — Other Current Assets: 20503000.00
CPRX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 417000.00
CPRX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 64000.00
CPRX balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 64000.00
CPRX income_statement (annual, 2024-12-31) — Other Gand A: 45924000.00
CPRX income_statement (annual, 2024-12-31) — Other Income Expense: 5075000.00
CPRX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 156672000.00
CPRX cash_flow (annual, 2024-12-31) — Other Non Cash Items: -557000.00
CPRX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 315000.00
CPRX balance_sheet (annual, 2024-12-31) — Other Payable: 3582000.00
CPRX balance_sheet (annual, 2024-12-31) — Other Properties: 2230000.00
CPRX balance_sheet (annual, 2024-12-31) — Other Receivables: 11000.00